The Modulation Effect of Non-invasive Brain Stimulation on Cognitive Function in Patients with Mild Cognitive Impairment: a Systematic Review and Meta-analysis of Randomized Controlled Trials
Overview
Affiliations
Background: To prevent and control dementia, many scholars have focused on the transition stage between normal ageing and dementia, mild cognitive impairment (MCI) which is a key interventional target for dementia. Studies have shown that non-invasive brain stimulation (NIBS) is beneficial to improve cognitive function of MCI patients. However, whether NIBS is conducive to the protection of cognitive ability in MCI patients remains unknown due to limited evidence. The aim of the study was to systematically evaluate the modulation effect of NIBS on cognitive function (global cognitive ability and specific domains of cognition) in patients with MCI.
Results: A total of 11 RCTs comprising a total of 367 MCI participants. Meta-analysis showed that NIBS can significantly improve global cognition (n = 271, SMD = 0.94, 95% CI 0.47-1.41, p < 0.0001) and verbal fluency (n = 72, MD = 2.03, 95% CI 0.17-3.88, p = 0.03). However, there was no significant improvement in other domains of cognition.
Conclusions: NIBS has a positive effect on improving global cognitive function and verbal fluency. At the same time, it has a small positive effect on improving executive function. However, these findings should be interpreted carefully due to the limitations of the study.
Yang T, Liu W, He J, Gui C, Meng L, Xu L Alzheimers Res Ther. 2024; 16(1):140.
PMID: 38937842 PMC: 11212379. DOI: 10.1186/s13195-024-01505-9.
Park J, Chung K, Oh Y, Kim K, Kim C, Park J Yonsei Med J. 2024; 65(6):341-347.
PMID: 38804028 PMC: 11130587. DOI: 10.3349/ymj.2023.0430.
Zhang L, Gao S, Wang C, Li Y, Yuan H, Cao L Front Neurol. 2024; 15:1378731.
PMID: 38715694 PMC: 11075487. DOI: 10.3389/fneur.2024.1378731.
From Lab to Life: Exploring Cutting-Edge Models for Neurological and Psychiatric Disorders.
Tanaka M, Vecsei L Biomedicines. 2024; 12(3).
PMID: 38540226 PMC: 10968028. DOI: 10.3390/biomedicines12030613.
Dolphin H, Dyer A, Dukelow T, Finucane C, Commins S, Kennelly S BMC Neurol. 2023; 23(1):289.
PMID: 37532979 PMC: 10394887. DOI: 10.1186/s12883-023-03320-5.